Literature DB >> 1892758

The uptake and retention of metaiodobenzyl guanidine by the neuroblastoma cell line NB1-G.

R J Mairs1, M N Gaze, A Barrett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1892758      PMCID： PMC1977500          DOI： 10.1038/bjc.1991.294

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  16 in total

1.  Radiation studies on multicellular tumour spheroids derived from human neuroblastoma: absence of sparing effect of dose fractionation.

Authors:  T E Wheldon; L Wilson; A Livingstone; J Russell; J O'Donoghue; A Gregor
Journal:  Eur J Cancer Clin Oncol       Date:  1986-05

2.  The radiosensitivity of human neuroblastoma cells estimated from regrowth curves of multicellular tumour spheroids.

Authors:  T E Wheldon; A Livingstone; L Wilson; J O'Donoghue; A Gregor
Journal:  Br J Radiol       Date:  1985-07       Impact factor: 3.039

3.  The effect on human neuroblastoma spheroids of fractionated radiation regimes calculated to be equivalent for damage to late responding normal tissues.

Authors:  T E Wheldon; I Berry; J A O'Donoghue; A Gregor; I M Hann; A Livingstone; J Russell; L Wilson
Journal:  Eur J Cancer Clin Oncol       Date:  1987-06

4.  Radionuclide therapy of neural crest tumors.

Authors:  P A Voûte; C A Hoefnagel; J de Kraker; A E Evans; A Hayes; A Green
Journal:  Med Pediatr Oncol       Date:  1987

5.  Modification by nifedipine of 131I-meta-iodobenzylguanidine kinetics in malignant phaeochromocytoma.

Authors:  G M Blake; V J Lewington; J S Fleming; M A Zivanovic; D M Ackery
Journal:  Eur J Nucl Med       Date:  1988

6.  Specific uptake of m-[125I]iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH.

Authors:  J Buck; G Bruchelt; R Girgert; J Treuner; D Niethammer
Journal:  Cancer Res       Date:  1985-12       Impact factor: 12.701

7.  Uptake and release of iodine-labelled m-iodobenzylguanidine in a neuroblastoma cell culture system and its importance in neuroblastoma therapy.

Authors:  V Paffenholz; U Ebener; B Kornhuber
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

8.  Sodium dependency of uptake of norepinephrine and m-iodobenzylguanidine into cultured human pheochromocytoma cells: evidence for uptake-one.

Authors:  S Jaques; M C Tobes; J C Sisson
Journal:  Cancer Res       Date:  1987-08-01       Impact factor: 12.701

9.  Comparison of the sodium dependency of uptake of meta-lodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells.

Authors:  S Jaques; M C Tobes; J C Sisson; J A Baker; D M Wieland
Journal:  Mol Pharmacol       Date:  1984-11       Impact factor: 4.436

10.  Biological properties of a tumour cell line (NB1-G) derived from human neuroblastoma.

Authors:  R Carachi; T Raza; D Robertson; T W Wheldon; L Wilson; A Livingstone; V van Heyningen; G Spowart; P Middleton; J R Gosden
Journal:  Br J Cancer       Date:  1987-04       Impact factor: 7.640
View more
  10 in total

Review 1.  Impact of medications on mIBG uptake, with specific attention to the heart: Comprehensive review of the literature.

Authors:  Arnold F Jacobson; Mark I Travin
Journal:  J Nucl Cardiol       Date:  2015-05-15       Impact factor: 5.952

Review 2.  Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry.

Authors:  A R Wafelman; C A Hoefnagel; R A Maes; J H Beijnen
Journal:  Eur J Nucl Med       Date:  1994-06

3.  Immunohistochemical evaluation of molecular radiotherapy target expression in neuroblastoma tissue.

Authors:  Jennifer E Gains; Neil J Sebire; Veronica Moroz; Keith Wheatley; Mark N Gaze
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-10-17       Impact factor: 9.236

4.  A 4-methyl-substituted meta-iodobenzylguanidine analogue with prolonged retention in human neuroblastoma cells.

Authors:  Ganesan Vaidyanathan; Philip C Welsh; Katia C Vitorello; Stacey Snyder; Henry S Friedman; Michael R Zalutsky
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-06-16       Impact factor: 9.236

5.  Inhibition of glycolysis and mitochondrial respiration promotes radiosensitisation of neuroblastoma and glioma cells.

Authors:  Donna L Nile; Colin Rae; David J Walker; Joe Canning Waddington; Isabel Vincent; Karl Burgess; Mark N Gaze; Robert J Mairs; Anthony J Chalmers
Journal:  Cancer Metab       Date:  2021-05-19

6.  131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.

Authors:  M N Gaze; R J Mairs; S M Boyack; T E Wheldon; A Barrett
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

7.  Prediction of accumulation of 131I-labelled meta-iodobenzylguanidine in neuroblastoma cell lines by means of reverse transcription and polymerase chain reaction.

Authors:  R J Mairs; A Livingstone; M N Gaze; T E Wheldon; A Barrett
Journal:  Br J Cancer       Date:  1994-07       Impact factor: 7.640

8.  Modification of meta-iodobenzylguanidine uptake in neuroblastoma cells by elevated temperature.

Authors:  A Armour; R J Mairs; M N Gaze; T E Wheldon
Journal:  Br J Cancer       Date:  1994-09       Impact factor: 7.640

Review 9.  Nothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapy.

Authors:  Keri A Streby; Nilay Shah; Mark A Ranalli; Anne Kunkler; Timothy P Cripe
Journal:  Pediatr Blood Cancer       Date:  2014-08-30       Impact factor: 3.167

10.  An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma.

Authors:  Donna L Nile; Colin Rae; Iain J Hyndman; Mark N Gaze; Robert J Mairs
Journal:  BMC Cancer       Date:  2016-08-11       Impact factor: 4.430
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.